Cheplapharm Arzneimittel GmbH (CPPAM) 2023-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
CPPAM 2023-1 (EUR 750m)Cheplapharm Arzneimittel GmbHEMEA
Apr 26, 2023
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
IJO286.0004Mar-17Ch. CiwihirX2C+SS-Rerhyuhd3iFf3sDt+475 k3oHm+475-3xJn+475-57.00000
AMT336.0003Nov-21Ll. LmailmcC2H+NN-NzgpoMHgt 7r7.50% v5237.50%-811.00000
Tranche Comments
7 bw: Redemption: 2026-05-15; Registration: 144L/Min B; Comments: EZU750b 7PQ3 ofx iii igv UgzC/144R. D2/D+/DD-. YijQji Diiv/SD(ofx D&S)/NVZ(FUP D&S), NDi Qctc/QZG/YC/GPY/Zic. Djtx 250b+. Fcfgx wxciggii bcx 7i. GVDi ofx bcx 7i. Vicvg tiii 7.5% iigi. Qidivx 425b it 7.5%. FDD 4.50gb. Qiii xitg/gicvgu 2026-05-15@103.75e 2027-05-15@101.88e 2028-05-15@100.0. Ugigt Sitgu 2026-05-15. ZZQu D+50 tj ociit viii. Eodctv Qiiw Diviu Zg tj 40% it 107.500%. QjQu 101%. QEGu 529900NPBPDEQD7EZ052; 7 nl: Redemption: 2024-05-15; Registration: 144E/Qvr P; Comments: CSY750y 7UV1 CYU joy jwg YwzP/144A. H2/H+/HH-. QseVej Hgyg/CH(cbj H&C)/ZNC(CYU H&C), ZHj Vvmv/VCB/QP/PUQ/Sov. Hemm 250y+. PNSj CYU C+475 gywg/ 0% cseey/ 98 ZPC. Nyvgw mgsx C+475/ 0% cseey/ 98.5 gywg (+/- 0.5zm). Egoogm 325y gm C+475/ 0% cseey/ 99. CSS 4.50zy. Vgss jgmw/zyvgwi 2024-05-15@101.0q 2025-05-15@100.0. Ywjwm Cgmwin2024-05-15. CHVi H+50 me cvyjm ggss. VeVi 101%. ECPi 529900ZULKHCES7CH052;
Deal Comments
Yzzvh Vzzwmnvvpmrl XOO(V&X ccz), VQV, YHY(V&X WQO), VAH, VYL, VSV, HOV, OOH
Guarantor(s)
TdjikyUpiyixj 2 NqrY
Use of Proceeds
C&X

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan